US 11761006
Use of MIR101 or MIR128 in the treatment of seizure disorders
granted A61KA61K35/761A61K9/0019
Quick answer
US patent 11761006 (Use of MIR101 or MIR128 in the treatment of seizure disorders) held by OVID THERAPEUTICS INC. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K35/761, A61K9/0019, A61K9/0085, A61K9/127